Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Cancer Stage 0”

44 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 44 results

Testing effectiveness (Phase 2)Study completedNCT00023842
What this trial is testing

BCG With or Without Mitomycin in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC 97
Not applicableLooking for participantsNCT06337942
What this trial is testing

Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study

Who this might be right for
Bladder DiseaseBladder, NeurogenicBladder Cancer+1 more
University of California, Los Angeles 5
Testing effectiveness (Phase 2)Study completedNCT00002917
What this trial is testing

Paclitaxel in Treating Patients With Early-Stage Bladder Cancer

Who this might be right for
Bladder Cancer
Mary Babb Randolph Cancer Center at West Virginia University Hospitals
Large-scale testing (Phase 3)Study completedNCT00006034
What this trial is testing

Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
Intracel
Large-scale testing (Phase 3)Study completedNCT00003814
What this trial is testing

Eflornithine in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
National Cancer Institute (NCI) 450
Large-scale testing (Phase 3)Study completedNCT00729287
What this trial is testing

Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
KU Leuven 276
Not applicableStudy completedNCT00744744
What this trial is testing

Health-Related Quality of Life in Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
David Latini 138
Not applicableStudy completedNCT04885309
What this trial is testing

Efficacy and Safety of Obturator Nerve Block During Transurethral Resection on Non-muscle Invasive Intermediate and High Risk Lateral Wall Bladder Tumours

Who this might be right for
Bladder Cancer Stage 0Bladder Cancer Stage I
Ankara Training and Research Hospital 104
Large-scale testing (Phase 3)UnknownNCT01094964
What this trial is testing

Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer

Who this might be right for
Bladder Cancer
Cancer Research Campaign Clinical Trials Centre 242
Large-scale testing (Phase 3)Study completedNCT00004154
What this trial is testing

Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 111
Large-scale testing (Phase 3)Study completedNCT01442519
What this trial is testing

Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer

Who this might be right for
Bladder Cancer
University of Rome Tor Vergata 212
Large-scale testing (Phase 3)UnknownNCT00003725
What this trial is testing

Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Who this might be right for
Bladder Cancer
Anthra Pharmaceuticals 300
Testing effectiveness (Phase 2)Study completedNCT00047216
What this trial is testing

Tipifarnib in Treating Patients With Recurrent Bladder Cancer

Who this might be right for
Bladder Cancer
University Health Network, Toronto
Very early researchStudy completedNCT01827618
What this trial is testing

Neoadjuvant Rapamycin in Patients Undergoing Radical Cystectomy

Who this might be right for
Invasive Bladder Cancer Stage II
The University of Texas Health Science Center at San Antonio 29
Large-scale testing (Phase 3)Study completedNCT00003779
What this trial is testing

Biological Therapy in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
Swiss Cancer Institute 40
Large-scale testing (Phase 3)Ended earlyNCT00042887
What this trial is testing

Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC 58
Not applicableStudy completedNCT04501913
What this trial is testing

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

Who this might be right for
Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage 0 Gastric Cancer AJCC v8+169 more
City of Hope Medical Center 22
Not applicableEnded earlyNCT01108003
What this trial is testing

Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery

Who this might be right for
Recurrent Bladder CancerStage 0 Bladder CancerStage I Bladder Cancer+2 more
Roswell Park Cancer Institute 7
Not applicableStudy completedNCT00772018
What this trial is testing

Quality of Life and Symptom Management in Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
David Latini 28
Very early researchEnded earlyNCT01479348
What this trial is testing

Imaging Study for FdCyd and THU Cancer Treatment

Who this might be right for
Head and Neck NeoplasmsLung NeoplasmsUrinary Bladder Neoplasms+1 more
National Cancer Institute (NCI) 5
Load More Results